Evidence map›Paper›PMID 41057440›Full record

ArticleScientific reports2025

Influence of subretinal drusenoid deposit on retinal sensitivity in age-related macular degeneration.

Soo Hyun Lim, Taffeta Ching Ning Yamaguchi, Rolf Herrmann, Eun Kyoung Lee, Kun Ho Bae, Un Chul Park, Kyu Hyoung Park, Chang Ki Yoon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Soo Hyun LimDepartment of Ophthalmology, Yonsei University College of Medicine, Yongin Severance Hospital, Yongin, Republic of Korea.
Taffeta Ching Ning YamaguchiBoehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach Riss, Germany.
Rolf HerrmannBoehringer Ingelheim Pharma GmbH & Co. KG, 88400, Biberach Riss, Germany.
Eun Kyoung LeeDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Daehak-ro, Jongno-gu, 101, Seoul, Republic of Korea.
Kun Ho BaeDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Daehak-ro, Jongno-gu, 101, Seoul, Republic of Korea.
Un Chul ParkDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Daehak-ro, Jongno-gu, 101, Seoul, Republic of Korea.
Kyu Hyoung ParkDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Daehak-ro, Jongno-gu, 101, Seoul, Republic of Korea.
Chang Ki YoonDepartment of Ophthalmology, Seoul National University College of Medicine, Seoul National University Hospital, Daehak-ro, Jongno-gu, 101, Seoul, Republic of Korea. syst18@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This retrospective study aimed to assess the impact of subretinal drusenoid deposit (SDD), also known as reticular pseudodrusen, on retinal sensitivity (RS) in patients with intermediate age-related macular degeneration (iAMD) using microperimetry. Eyes meeting the modified criteria of iAMD, including SDD, and total drusen area greater than 0.50 mm

Indexed as

Macular DegenerationRetinaRetinal DrusenAgedAged, 80 and overFemaleFluorescein AngiographyHumansMaleMiddle AgedRetrospective StudiesTomography, Optical CoherenceVisual Field TestsIntermediate age-related macular degenerationMicroperimetryReticular pseudodrusenRetinal sensitivitySubretinal drusenoid deposit

Identifiers

PMID41057440
PMCPMC12504450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.